HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chow, Y.-H. Articles by Jove, R. Search for Related Content PubMed PubMed Citation Articles by Chow, Y.-H. Articles by Jove, R. Social Bookmarking                      What's this?

Volume 270, Number 23, Issue of June 9, pp. 14100-14106, 1995
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Yu-Hua Chow , Kevin Pumiglia , Toni H. Jun , Paul Dent , Thomas W. Sturgill , Richard Jove

Raf-1 is a serine/threonine kinase poised at a key relay point in mitogenic signal transduction pathways from the cell surface to the nucleus. Activation of the transforming potential of Raf-1 has been associated with N-terminal truncation and/or fusion to other proteins, suggesting that the Raf-1 N-terminal half harbors a negative regulatory domain. Seven internal deletion mutants that together scan the entire N-terminal half of human Raf-1 protein were generated to map functional regions in this regulatory domain. Effects of the deletion mutations on kinase activity of Raf-1 were evaluated using a baculovirus/insect cell overexpression system and an in vitro kinase assay with the known physiological substrate of Raf-1, mitogen-activated protein kinase kinase. Deletion of amino acids 276-323 in the unique sequence between conserved regions 2 and 3 leads to modest elevation of Raf-1 basal kinase activity, whereas deletion of amino acids 133-180 in conserved region 1 results in diminished kinase activity. Surprisingly, none of the Raf-1 N-terminal deletion mutants, including a truncated version that is transforming in rodent fibroblasts, exhibits greatly increased levels of basal kinase activity. In addition, while activation of Raf-1 kinase by Ras requires sequences in conserved region 1, only the C-terminal half containing the kinase domain of Raf-1 is required for activation by Src. These findings demonstrate that N-terminal deletions in Raf-1 do not necessarily result in constitutively elevated basal kinase activity and that the N-terminal regulatory domain is completely dispensable for Raf-1 activation by Src.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				M. Li, S. S. Ong, B. Rajwa, V. T. Thieu, R. L. Geahlen, and M. L. Harrison The SH3 Domain of Lck Modulates T-Cell Receptor-Dependent Activation of Extracellular Signal-Regulated Kinase through Activation of Raf-1 Mol. Cell. Biol., January 15, 2008; 28(2): 630 - 641. [Abstract] [Full Text] [PDF]

				, , , , , , , and The Cysteine-rich Regions of the Regulatory Domains of Raf and Protein Kinase C as Retinoid J. Exp. Med., September 18, 2000; 192(6): 835 - 846. [Abstract] [Full Text] [PDF]

				T.-H. Chao, M. Hayashi, R. I. Tapping, Y. Kato, and J.-D. Lee MEKK3 Directly Regulates MEK5 Activity as Part of the Big Mitogen-activated Protein Kinase 1 (BMK1) Signaling Pathway J. Biol. Chem., December 17, 1999; 274(51): 36035 - 36038. [Abstract] [Full Text] [PDF]

				J. K. Slack, A. D. Catling, S. T. Eblen, M. J. Weber, and J. T. Parsons c-Raf-mediated Inhibition of Epidermal Growth Factor-stimulated Cell Migration J. Biol. Chem., September 17, 1999; 274(38): 27177 - 27184. [Abstract] [Full Text] [PDF]

				N. Grammatikakis, J.-H. Lin, A. Grammatikakis, P. N. Tsichlis, and B. H. Cochran p50cdc37 Acting in Concert with Hsp90 Is Required for Raf-1 Function Mol. Cell. Biol., March 1, 1999; 19(3): 1661 - 1672. [Abstract] [Full Text] [PDF]

				A. D. Laird, D. K. Morrison, and D. Shalloway Characterization of Raf-1 Activation in Mitosis J. Biol. Chem., February 12, 1999; 274(7): 4430 - 4439. [Abstract] [Full Text] [PDF]

				M. Daub, J. Jöckel, T. Quack, C. K. Weber, F. Schmitz, U. R. Rapp, A. Wittinghofer, and C. Block The RafC1 Cysteine-Rich Domain Contains Multiple Distinct Regulatory Epitopes Which Control Ras-Dependent Raf Activation Mol. Cell. Biol., November 1, 1998; 18(11): 6698 - 6710. [Abstract] [Full Text]

				D.-b. Chen, S. D. Westfall, H. W. Fong, M. S. Roberson, and J. S. Davis Prostaglandin F2{alpha} Stimulates the Raf/MEK1/Mitogen-Activated Protein Kinase Signaling Cascade in Bovine Luteal Cells Endocrinology, September 1, 1998; 139(9): 3876 - 3885. [Abstract] [Full Text] [PDF]

				L. F. Stancato, A. M. Silverstein, J. K. Owens-Grillo, Y.-H. Chow, R. Jove, and W. B. Pratt The hsp90-binding Antibiotic Geldanamycin Decreases Raf Levels and Epidermal Growth Factor Signaling without Disrupting Formation of Signaling Complexes or Reducing the Specific Enzymatic Activity of Raf Kinase J. Biol. Chem., February 14, 1997; 272(7): 4013 - 4020. [Abstract] [Full Text] [PDF]

				J. K. Drugan, R. Khosravi-Far, M. A. White, C. J. Der, Y.-J. Sung, Y.-W. Hwang, and S. L. Campbell Ras Interaction with Two Distinct Binding Domains in Raf-1 May Be Required for Ras Transformation J. Biol. Chem., January 5, 1996; 271(1): 233 - 237. [Abstract] [Full Text] [PDF]